Patent · US Active

Combination of the application of antibodies for immunostimulation together with glucocorticoids

US8709421B2 · kind B2 · utility

50Cited by

5References

15Claims

0Family size

Assignee

Trion Pharma GmbH · DE

Inventors

Markus M. Heiss · Cologne, DE
Horst Lindhofer · Puchheim, DE

Key dates

Filing date	Oct 26, 2007
Grant date	Apr 29, 2014
Priority date	—
Expiry date	Sep 3, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods for reducing or eliminating the non-specific release of a cytokine associated with a disease comprising administering at least one glucocorticoid and an immunostimulating antibody. Additionally, the present invention relates to a pharmaceutical composition that contains at least one immunostimulating antibody and at least one glucocorticoid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.